Evaluating the effectiveness and costs of remote methadone treatment for opioid use disorder
Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care
This study is looking at how a new online tool can help people taking methadone for opioid addiction, especially those using fentanyl, by making sure they take their medicine correctly and safely from home, which could lead to better care and easier access to treatment.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sonara Health INC NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11084433 on NIH RePORTER |
What this research studies
This research investigates the use of a web-based application to monitor patients taking methadone for opioid use disorder, particularly those using fentanyl. The study aims to assess the retention rates and costs associated with this remote observed dosing method, especially in light of changes to regulations during the COVID-19 pandemic. By utilizing video recordings and tamper-evident seals, the research seeks to ensure that methadone is consumed as prescribed, thereby promoting safer access to take-home doses. The findings could help improve patient-centered care and access to treatment for those struggling with severe opioid addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with severe opioid use disorder, particularly those using fentanyl and seeking methadone treatment.
Not a fit: Patients who are not struggling with opioid use disorder or those who do not require methadone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance access to effective methadone treatment for opioid use disorder, potentially reducing overdose rates and improving patient outcomes.
How similar studies have performed: Previous research has shown promising results with remote monitoring approaches in addiction treatment, indicating potential for success in this novel application.
Where this research is happening
Dallas, United States
- Sonara Health INC — Dallas, United States (Active)
Researchers
- Principal investigator: Giles, Michael — Sonara Health INC
- Study coordinator: Giles, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.